Correction: TET2 deficiency promotes MDS-associated leukemogenesis - Takeaways - MDSpire

Correction: TET2 deficiency promotes MDS-associated leukemogenesis

  • By

  • Feiteng Huang

  • Jie Sun

  • Wei Chen

  • Lei Zhang

  • Xin He

  • Haojie Dong

  • Yuhui Wu

  • Hanying Wang

  • Zheng Li

  • Brian Ball

  • Samer Khaled

  • Guido Marcucci

  • Ling Li

  • November 28, 2023

  • 0 min

Share

  • 1

    The article is a correction to a previously published study in Blood Cancer Journal.

  • 2

    The correction addresses inaccuracies in the Acknowledgements section of the original article.

  • 3

    Funding sources include National Institutes of Health and American Cancer Society grants.

  • 4

    Specific grant numbers mentioned are R01 HL141336, R01 CA248149, and RSG-19-036-01-LIB.

  • 5

    The correction was published online on October 4, 2022.

Original Source(s)

Correction: TET2 deficiency promotes MDS-associated leukemogenesis

  • by Feiteng Huang, Jie Sun, Wei Chen, Lei Zhang, Xin He, Haojie Dong, Yuhui Wu, Hanying Wang, Zheng Li, Brian Ball, Samer Khaled, Guido Marcucci, Ling Li

  • November 28, 2023

Related Content

A serum exosomal four-miRNA signature for the diagnosis of central precocious puberty: a discovery and validation study

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

Protocol for a randomized controlled trial investigating the effects of sleep extension on body weight and learning in children (More2Sleep)